Quantcast Pharmaceutical Industry News - Congoo
 
 
Log In
  INDUSTRY >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Accounting
Advertising & marketing
Advertising industry
Aerospace & defense
Agriculture
Airline industry
Automotive industry
Banking
beverage related
Biological sciences
Biotech
Book publishing
Broadcasting industry
Business
Cable industry
Cancer
Charities
Chemicals industry
Climate change
Clothing industry
Coal industry
Commodities
Communications equipment
Computer games
Computer security
Computer services
Construction
Corporate finance
Corporate governance
Crime & Punishment
CRM
Database industry
Derivatives
Developer
Digital television
Drinks & beverage industry
Durable goods
E-commerce
Economics
Electronics
Emerging markets
Energy
Engineering Industry
Enterprise computing
Entrepreneur
Environment
Equity markets
Fashion
Fed watch
Finance related
Firearms industry
Fitness
Food and drink
Food industry
Forex markets
Fund management
Gaming
Genetics
government: general
Graphics industry
Handhelds
Healthcare
Horse racing
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
International development
International Paper Company
International relations
Internet news
IP and patents
IPO
Java
Job markets
Journalism
Knowledge management
Law
Leisure goods
Linux
Logistics
Management
Manufacturing
Marketing
Media
Medical
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Nanotechnology
Newspaper publishing
Oil & gas
Online access
Online broker
Online content
Online information
Online marketing
Online portals
Open source
OS news
Outdoor recreation
Outsourcing
Packaging & paper
Paper
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Police
Pop music
Public health
Real Estate industry
Recreation
Religion
Retail investor
Retail sector
RFID
Robotics
RSS
Science
Search Engines
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Space science
Steelmaking
Tech stocks
Technology
Telecom industry
television: general
Textiles
Tobacco industry
Trade
Transportation industry
Travel & Vacation
Travel industry
US banking
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Wireless sector
XML & metadata
 
 



ACADIA Pharmaceuticals submits new drug application for NUPLAZID for the Treatment   - 9/3/2015
7:00am EDT   ACADIA Pharmaceuticals Inc:Announces it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for NUPLAZID (pimavanserin) for the treatment
  
    



AJ Khubani to Receive ERA Lifetime Achievement Award at 2015 ERA D2C Convention   - 9/3/2015
FAIRFIELD, N.J., Sept. 3, 2015 /PRNewswire/ -- The Electronic Retailing Association (ERA) announced that AJ Khubani, Founder and CEO of TeleBrands Corporation, will be honored with the prestigious 2015
  
    




Medtronic Profit Exceeds Estimates on New Heart Device Demand   - 9/3/2015
8:11 am ET (Bloomberg) -- Medtronic Plc, the world’s biggest maker of heart-rhythm devices, reported first-quarter profit that topped analysts’ estimates on strong demand for its newest products to
  
    



XTL Biopharmaceuticals to Present at the Rodman & Renshaw 17th Annual Global Investment   - 9/3/2015
PR Newswire RA'ANANA, Israel, September 3, 2015 RA'ANANA, Israel , September 3, 2015 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage
all 1 news articles >>
  
    



CytRx Announces the Presentation of its Phase 2b Clinical Trial Design in Small   - 9/3/2015
PR Newswire LOS ANGELES, Sept. 3, 2015 LOS ANGELES , Sept. 3, 2015 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology,
all 1 news articles >>
  
    



REG-Form 8.3 - Betfair Group Plc   - 9/3/2015
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY
all 54 news articles >>
  
    


Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit




Technomedia Delivers Second Feature Pack for 2015 and Introduces a New Core HR Hub   - 9/3/2015
Your requested update has been submitted Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If
all 11222 news articles >>
  
    



Innovus Pharmaceuticals reports first shipment of EjectDelay (Uxor) in Canada   - 9/3/2015
OTC health company Innovus Pharmaceuticals (OtherOTC:INNV) said on Thursday that its partner Orimed has received the first commercial shipment of EjectDelay for the Canadian market and EjectDelay will
  
    



Glenmark's Novel Monoclonal Antibody GBR 830 to Enter Phase 2 Clinical Studies in   - 9/3/2015
/PRNewswire/ -- - GBR 830 Completes Clinical Phase 1 Successfully in The Netherlands - The Antibody has Been Well Tolerated With a Favourable Pharmacokinetic Profile - GBR 830 is the First OX40
all 3 news articles >>
  
    


Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More



Xenon Pharmaceuticals to Present at the 10th Annual Wells Fargo Healthcare Conference   - 9/3/2015
BURNABY, British Columbia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's President
  
    



Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 17th Annual Global Investment   - 9/3/2015
CORAL GABLES, Fla., Sept. 03, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals , Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people
all 7 news articles >>
  
    



GenomeDx Biosciences to Present at Baird 2015 Healthcare Conference   - 9/3/2015
PR Newswire SAN DIEGO, Sept. 3, 2015 SAN DIEGO , Sept. 3, 2015 /PRNewswire/ -- GenomeDx Biosciences announced that it will present at the Baird 2015 Healthcare Conference on Thursday, September
all 1 news articles >>
  
    


Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More



Arena Pharmaceuticals to Present at the Wells Fargo 2015 Healthcare Conference   - 9/3/2015
PR Newswire SAN DIEGO, Sept. 3, 2015 SAN DIEGO , Sept. 3, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview
all 2 news articles >>
  
    



G1 Therapeutics to Present at September Biotech Conferences   - 9/3/2015
RESEARCH TRIANGLE PARK, N.C., Sept. 3, 2015 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present
  
    



Immune Pharmaceuticals Holds First R&D Day On September 8, 2015   - 9/3/2015
PR Newswire NEW YORK, Sept. 3, 2015 NEW YORK , Sept. 3, 2015 /PRNewswire/ -- Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ("Immune" or the "Company") announced today that its first R&D day will
  
    



Faraday Pharmaceuticals Announces the Appointment of Dr. Stephen A. Hill as Chief   - 9/3/2015
PR Newswire SEATTLE, Sept. 3, 2015 SEATTLE , Sept. 3, 2015 /PRNewswire/ -- Faraday Pharmaceuticals today announced the appointment of Stephen A. Hill, M.D., as Chief Executive Officer. Dr. Hill
all 1 news articles >>
  
    



AMRI Appoints Christopher Conway to Lead AMRI Global Discovery and Development Services   - 9/3/2015
PR Newswire ALBANY, N.Y., Sept. 3, 2015 ALBANY, N.Y. , Sept. 3, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) is pleased to announce that it has appointed Christopher Conway as Senior Vice President
all 3 news articles >>
  
    



FDA Grants QIDP Designation and Fast Track Status to TP-271   - 9/3/2015
WATERTOWN, Mass., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease
  
    



Zogenix to Participate in the Wells Fargo 2015 Healthcare Conference   - 9/3/2015
SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that
  
    



CoLucid Pharmaceuticals to Present at Two Investor Conferences in September   - 9/3/2015
CAMBRIDGE, Mass., Sept. 3, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD) today announced that Thomas P. Mathers, Chief Executive Officer, will provide a corporate overview at two
  
    



Momenta Pharmaceuticals to Webcast Presentation at the Morgan Stanley Global Healthcare   - 9/3/2015
CAMBRIDGE, Mass., Sept. 03, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today
all 1 news articles >>
  
    



Kite Pharma to Participate in Upcoming Investor Conferences in September 2015   - 9/3/2015
SANTA MONICA, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that the management team will participate in two upcoming investor conferences this month: 10th
  
    



Quintiles CEO to Present at Morgan Stanley Global Healthcare Conference   - 9/3/2015
September 16, 2015 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles CEO Tom Pike will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2015 in
  
    



Neurocrine Biosciences Announces the Appointment of Dr. Alfred W. Sandrock to its   - 9/3/2015
SAN DIEGO, Sept. 3, 2015 /PRNewswire/ --   Neurocrine Biosciences , Inc. (NASDAQ: NBIX) announced today that it has appointed Alfred W. Sandrock, Jr., M.D., Ph.D. to its Board of Directors effective immediately.
all 6 news articles >>
  
    



First Biosimilar Goes on Sale in U.S., Challenging Amgen   - 9/3/2015
Novartis AG began selling the first copy of a biotechnology drug in the U.S., offering a 15 percent discount to the original after a U.S. appeals court rejected Amgen Inc.’s last-ditch effort to protect
  
    
*Votes may take up to 30 minutes to influence article rank order


Featured Members
Joan Bradley Joan Bradley
President
Pharma Industry
Frank Forney Frank Forney
Pharma Industry
Allison Gerard Allison Gerard
Research Director
Pharma Industry
Nancy Deeg Nancy Deeg
CEO
Pharma Industry

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.